ITG (Germany) Announces Broad Collaboration With ANSTO (Australia) on Radioisotopes
GARCHING, Germany, June 3, 2011 /PRNewswire/ -- ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative radioisotopes, and Sydney-based, Australian Nuclear Science and Technology Organisation (ANSTO) have agreed on a broad, long-term collaboration on radioisotopes.
ANSTO has in-licensed the production technology for ITG's carrier free Lutetium-177 (Lu-177 n.c.a.) and will be the exclusive distribution partner for ITG's products in Australia & New Zealand.
Both partners have agreed to provide each other with a backup supply of the radioisotope when needed as well as forming a collaboration for the supply of Lu-177 n.c.a. to industrial partners in the life science industry. Financial terms were not disclosed.
Dr. Richard Henkelmann and Dr. Andreas Hey, Managing Directors of ITG, stated "This agreement is a significant milestone in the corporate development of our company and serves as proof of the value of our production technology for Lu-177 n.c.a. It sends a strong signal to those companies developing Lutetium-177-based radiotherapies that global supply is guaranteed. Furthermore, adding ANSTO to our existing network of world-wide distribution partners closes an important geographical gap".
Mr Doug Cubbin, Head of ANSTO's Business Development and Commercialisation said "This is a great opportunity for ANSTO and the Asia Pacific region as it will accelerate the availability of locally produced Lu-177 within the region and the collaboration between ANSTO and ITG will underpin the future supply of an important radioisotope".
About ITG: ITG Isotope Technologies Garching GmbH, a subsidiary of ITM Isotopen Technologien Muenchen AG (http://www.itm.ag), develops, manufactures and distributes world-wide innovative radio-isotopes for use in diagnosis and therapy.
About ANSTO: The Australian Nuclear Science and Technology Organisation produces radioisotopes, isotopic techniques and nuclear radiation for medicine, science, industry, commerce and agriculture as one of its core functions. For more please visit: http://www.ansto.gov.au
Your contact partner for any enquiries:
ITG Isotope Technologies Garching GmbH, Dr. Andreas Hey, Lichtenbergstr. 1, 85748 Garching, Tel.: +49(89)289-13913, [email protected]
SOURCE ITG Isotope Technologies Garching GmbH
Share this article